Xtant Medical Holdings, Inc.

XTNT NYSE CIK: 0001453593

Company Information

Industry Surgical & Medical Instruments & Apparatus
SIC Code 3841
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting company
State of Incorporation DE
Business Address 664 CRUISER LANE, BELGRADE, MT, 59714
Mailing Address 664 CRUISER LANE, BELGRADE, MT, 59714
Phone 406-388-0480
Fiscal Year End 1231
EIN 205313323

Financial Overview

FY2025

$4.97M
Net Income

Recent SEC Filings

Form Type Date Filed Document
10-K Annual financial report March 31, 2026 View on SEC
8-K Current report of material events March 31, 2026 View on SEC
8-K Current report of material events March 2, 2026 View on SEC
4 Insider stock transaction report February 18, 2026 View on SEC
SCHEDULE 13G/A Passive ownership amendment February 17, 2026 View on SEC
4 Insider stock transaction report January 16, 2026 View on SEC
8-K Current report of material events January 16, 2026 View on SEC
8-K Current report of material events December 3, 2025 View on SEC
4 Insider stock transaction report November 18, 2025 View on SEC
4 Insider stock transaction report November 18, 2025 View on SEC

Annual Reports

10-K March 31, 2026
  • Strategic pivot toward high-profit proprietary biological materials, which now comprise 60% of total revenue.
  • Significant debt reduction and improved cash position following the sale of non-core assets.
View Analysis

Material Events

8-K Strategy Change March 2, 2026
High Impact
  • Significant cash inflow of $10.7 million from asset sale.
  • Reduced debt by $2.8 million, strengthening the balance sheet.
View Analysis

Related Companies

Companies in the same industry (SIC: 3841)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.